Hypertension

>

Latest News

FDA Approves Aprocitentan (Tryvio) for Treatment-Resistant Hypertension in Landmark Decision
FDA Approves Aprocitentan (Tryvio) for Treatment-Resistant Hypertension in Landmark Decision

March 20th 2024

Aprocitentan is the first antihypertensive drug approved in more than 30 years that achieves its effect through a unique therapeutic pathway.

Early Detection of CKD Progression in Primary Care: Daily Dose / image credit: ©New Africa/AdobeStock
Early Detection of CKD Progression in Primary Care: Daily Dose

March 12th 2024

Zilebesiran Reduces Hypertension as Addition to Standard of Care in Phase 2 KARDIA-2 Trial / image credit blood pressure cuff and medications: ©Rostick/stock.adobe.com
Zilebesiran Reduces Uncontrolled Hypertension as Addition to Standard of Care in Phase 2 KARDIA-2 Trial

March 5th 2024

Rapid Progression of CKD Can Be Detected Early Using Simple Markers in Primary Care / Image credit kidney disease progression: ©pikovit/stock.adobe.com
Rapid Progression of CKD Can Be Detected Early Using Simple Markers in Primary Care

March 4th 2024

Salt Substitute Reduces HTN Risk among Older Adults with Normal BP: Daily Dose / image credit: ©New Africa/AdobeStock
Salt Substitute Reduces HTN Risk among Older Adults with Normal BP: Daily Dose

February 28th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.